Design, synthesis, and evaluation of benzothiadiazepine hydroxamates as selective tumor necrosis factor-alpha converting enzyme inhibitors.

Source:http://linkedlifedata.com/resource/pubmed/id/12723945

J. Med. Chem. 2003 May 8 46 10 1811-23

Download in:

View as

General Info

PMID
12723945